Diabetes: Hormone Replacement Therapy
The question
To ask the Secretary of State for Health and Social Care, if he will hold discussions with NICE on providing up-to-date guidance for clinicians on the provision of HRT to people with Type 1 diabetes mellitus.
Answered by Ashley Dalton
There are currently no plans to ask the National Institute for Health and Care Excellence (NICE) to develop guidance on the provision of HRT to people with Type 1 diabetes mellitus.
Topics for new or updated guidance are considered through the NICE prioritisation process. Decisions as to whether NICE will create new, or update existing, guidance are overseen by a prioritisation board, chaired by NICE’s Chief Medical Officer.
NICE makes independent, evidence-based recommendations for the health and care system on best practice. It is right that decisions on the topics to be prioritised for guidance development should be based on the evidence and in line with NICE’s process.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →